<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00987259</url>
  </required_header>
  <id_info>
    <org_study_id>BLT006964</org_study_id>
    <nct_id>NCT00987259</nct_id>
  </id_info>
  <brief_title>Myocardial Oedema in Acute Myocardial Infarction (AMI)</brief_title>
  <official_title>Determination of the Time Course of Myocardial Oedema Post Myocardial Infarction Treated With Primary Angioplasty Using Cardiac Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barts &amp; The London NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite recent improvements in treatment, myocardial infarction (heart attack) is still a
      leading cause of illness and death in the UK. Following the acute event, it is difficult to
      predict which patients are at risk of further problems, such as heart failure and is
      therefore difficult to know which patients need more aggressive/intensive treatment and
      monitoring.

      There needs to be a test which is safe, reliable and reproducible that can be used shortly
      after a heart attack to both predict future cardiac events and to allow the efficacy of new
      treatments to be assessed.

      Myocardial oedema (swelling of the heart muscle) has been demonstrated using Cardiac Magnetic
      Resonance (CMR), to occur following a heart attack and has been suggested as a marker for
      future cardiac events. The optimum time to perform this scan, the method of data analysis and
      it's effectiveness as a predictor of future cardiac events has not been adequately assessed.

      This trial will assess the amount and natural time-course of oedema in the first 10 days
      following a heart attack. It will also correlate the amount of oedema with the size of scar
      (damaged heart muscle) and left ventricular ejection fraction (heart function) at 3 months to
      assess if it is a predictive marker.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Extent and time course of myocardial oedema over the first 10 days post MI</measure>
    <time_frame>Days 1, 3 and 10 post MI</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular ejection fraction and left ventricular scar size at 3 months</measure>
    <time_frame>90 days post MI</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Post MI patients</arm_group_label>
    <description>Patients recruited following a successfully reperfused myocardial infarction using primary angioplasty.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to The London Chest Hospital following an ST elevation myocardial
        infarction who have been successfully treated with primary angioplasty.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients presenting to the London Chest Hospital with acute ST elevation myocardial
             infarction and treated with primary angioplasty and stent implantation within 12 hours
             of symptom onset

          2. Acute PCI / stent implantation has been successful (residual stenosis visually &lt; 30%
             and TIMI flow ≥ 2)

          3. At the time of inclusion, the patient no longer requires intravenous catecholamines or
             mechanical hemodynamic support (aortic balloon pump)

          4. Serum troponin &gt;1ng/ml 12 hours after onset of pain

          5. The patient is able to give written informed consent

          6. The patient must be able to understand and communicate in English

        Exclusion Criteria:

          1. Known cardiomyopathy

          2. Previous documented myocardial infarction

          3. Previous percutaneous coronary intervention or coronary artery bypass surgery

          4. Significant renal dysfunction (EGFR&lt;30)

          5. Systemic steroid therapy

          6. Current non steroidal anti-inflammatory drug use

          7. Chronic inflammatory disease

          8. Neoplastic disease without documented remission within the past 5 years

          9. Pregnancy

         10. Reduced mental capacity leading to inability to obtain informed consent

         11. Participation in another clinical trial within the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas R Burchell, BSc, MB BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bart's and The London NHS Trust, United Kingdom</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The London Chest Hospital</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>E2 9JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, Crooks LE. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983 Jul;52(1):184-8.</citation>
    <PMID>6858909</PMID>
  </reference>
  <reference>
    <citation>Laine GA, Granger HJ. Microvascular, interstitial, and lymphatic interactions in normal heart. Am J Physiol. 1985 Oct;249(4 Pt 2):H834-42.</citation>
    <PMID>4051019</PMID>
  </reference>
  <reference>
    <citation>Nilsson JC, Nielsen G, Groenning BA, Fritz-Hansen T, Sondergaard L, Jensen GB, Larsson HB. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart. 2001 Jun;85(6):639-42.</citation>
    <PMID>11359743</PMID>
  </reference>
  <reference>
    <citation>García-Dorado D, Oliveras J, Gili J, Sanz E, Pérez-Villa F, Barrabés J, Carreras MJ, Solares J, Soler-Soler J. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993 Aug;27(8):1462-9. Erratum in: Cardiovasc Res 1993 Oct;27(10):1889.</citation>
    <PMID>8297415</PMID>
  </reference>
  <reference>
    <citation>Bragadeesh T, Jayaweera AR, Pascotto M, Micari A, Le DE, Kramer CM, Epstein FH, Kaul S. Post-ischaemic myocardial dysfunction (stunning) results from myofibrillar oedema. Heart. 2008 Feb;94(2):166-71. Epub 2007 Jul 16.</citation>
    <PMID>17639092</PMID>
  </reference>
  <reference>
    <citation>Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005 Jun 7;45(11):1815-22.</citation>
    <PMID>15936612</PMID>
  </reference>
  <reference>
    <citation>Arai AE. Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios. Circulation. 2008 Aug 19;118(8):795-6. doi: 10.1161/CIRCULATIONAHA.108.797373.</citation>
    <PMID>18711021</PMID>
  </reference>
  <reference>
    <citation>Klem I, Kim RJ. Assessment of microvascular injury after acute myocardial infarction: importance of the area at risk. Nat Clin Pract Cardiovasc Med. 2008 Dec;5(12):756-7. doi: 10.1038/ncpcardio1373. Epub 2008 Oct 14.</citation>
    <PMID>18852712</PMID>
  </reference>
  <reference>
    <citation>Tilak GS, Hsu LY, Hoyt RF Jr, Arai AE, Aletras AH. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol. 2008 Jan;43(1):7-15.</citation>
    <PMID>18097272</PMID>
  </reference>
  <reference>
    <citation>Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, Arai AE. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006 Apr 18;113(15):1865-70. Epub 2006 Apr 10.</citation>
    <PMID>16606793</PMID>
  </reference>
  <reference>
    <citation>Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008 Apr 22;51(16):1581-7. doi: 10.1016/j.jacc.2008.01.019.</citation>
    <PMID>18420102</PMID>
  </reference>
  <reference>
    <citation>Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich MG. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol. 2003 Aug 6;42(3):513-8.</citation>
    <PMID>12906982</PMID>
  </reference>
  <reference>
    <citation>Ripa RS, Nilsson JC, Wang Y, Søndergaard L, Jørgensen E, Kastrup J. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. Am Heart J. 2007 Nov;154(5):929-36.</citation>
    <PMID>17967600</PMID>
  </reference>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2009</study_first_submitted>
  <study_first_submitted_qc>September 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2009</study_first_posted>
  <last_update_submitted>January 31, 2013</last_update_submitted>
  <last_update_submitted_qc>January 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>Myocardial oedema</keyword>
  <keyword>Magnetic resonance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

